What is Giant Biogene Holding Co Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Giant Biogene Holding Co's Average Total Inventories for the quarter that ended in Dec. 2023 was HK$212 Mil. Giant Biogene Holding Co's Revenue for the
six
months ended in Dec. 2023 was HK$2,098 Mil.
Giant Biogene Holding Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.10.
Giant Biogene Holding Co's Inventory-to-Revenue for the quarter that ended in Dec. 2023
declined
from Jun. 2023 (0.12) to Jun. 2023 (0.10)
A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Giant Biogene Holding Co's Days Inventory for the
six
months ended in Dec. 2023 was 109.55.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Giant Biogene Holding Co's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.67.
Giant Biogene Holding Co Inventory-to-Revenue Historical Data
The historical data trend for Giant Biogene Holding Co's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Giant Biogene Holding Co Inventory-to-Revenue Chart
Competitive Comparison of Giant Biogene Holding Co's Inventory-to-Revenue
For the Household & Personal Products subindustry, Giant Biogene Holding Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Giant Biogene Holding Co's Inventory-to-Revenue Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Giant Biogene Holding Co's Inventory-to-Revenue falls into.
Giant Biogene Holding Co Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Giant Biogene Holding Co's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giant Biogene Holding Co (HKSE:02367) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Giant Biogene Holding Co's Days Inventory for the
six
months ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Giant Biogene Holding Co Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Giant Biogene Holding Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Giant Biogene Holding Co (HKSE:02367) Business Description
Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02367 has been successfully added to your